Also, Rastgoo et al. reported that RBPMS restauration by overexpressing miR-138 re-sensitized multiple myeloma cells to the proteasome inhibitor bortezomib (BTZ) [77]. The gene discussed is RBPMS; the disease is AL amyloidosis.